GLG News Analyses of the following article:
REMERON(R) Now Approved In Japan For The Treatment Of Depression In Adult Patients
Published at: www.medicalnewstoday.com
-
July 13, 2009
Remeron has a unique mechanism of action which sets it apart from most other antidepressant drugs such as the SSRI's, the SNRI's, the TCA's, and the MAO-Inhibitors. It can be of great benefit to patients who do not respond to these other drugs.
- Subscribe to Updates
-
Work for one of the world's leading organizations? Get started now.
Get Intelligently Connected
with the world's leading experts
GLG's 850+ Clients Include:
- More than 70% of the world's leading
- mutual funds
- 15 of the leading 20
- global banks
- 9 of the leading 10
- global private equity firms
- 5 of the leading 10
- AmLaw firms
- Fortune 500® Companies
- in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.